April 2019

X4 Pharmaceuticals Prices $85.8 Million Public Offering of Common Stock and Class A Warrants – Business Wire

X4 Pharmaceuticals Prices $85.8 Million Public Offering of Common Stock and Class A Warrants Business Wire X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment.

X4 Pharmaceuticals Prices $85.8 Million Public Offering of Common Stock and Class A Warrants – Business Wire Read More »

Oil & Gas Company's 'Borrowing Base Confirmed,' 2019 Capital Program Fully Funded

Source: Streetwise Reports 04/12/2019 This finance news was covered in a Mackie Research Capital Corp. report. In an April 10 research note, Mackie Research Capital Corp. analyst Bill Newman reported that Prairie Provident Resources Inc.’s (PPR:TSX) US$60 million, senior-secured revolving note facility was confirmed. At year-end 2018, the company had drawn US$49 million on it.

Oil & Gas Company's 'Borrowing Base Confirmed,' 2019 Capital Program Fully Funded Read More »

Scroll to Top